Palisade Bio Inc. (PALI) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Palisade Bio Inc.

    NASDAQ: PALI · Real-Time Price · USD
    0.60
    0.02 (3.09%)
    At close: Sep 12, 2025, 3:59 PM
    0.60
    0.00%
    After-hours: Sep 12, 2025, 04:10 PM EDT

    Palisade Bio Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a 250K n/a n/a
    Cost of Revenue
    		 3K 4K 167K 168K
    Gross Profit
    		 -3K 250K -167K -168K
    Operating Income
    		 -14.86M -13.07M -15.72M -11.74M
    Interest Income
    		 n/a n/a 13K 3.08M
    Pretax Income
    		 -14.44M -12.3M -14.26M -26.62M
    Net Income
    		 -14.44M -12.3M -14.26M -26.62M
    Selling & General & Admin
    		 5.8M 6.2M 8.76M 9.31M
    Research & Development
    		 9.06M 6.89M 6.55M 2.43M
    Other Expenses
    		 n/a 225K 158K n/a
    Operating Expenses
    		 14.86M 13.32M 15.14M 11.74M
    Interest Expense
    		 12K 15K 13K 2.4M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 14.86M 13.32M 15.31M 41.85M
    Income Tax Expense
    		 n/a n/a n/a 655K
    Shares Outstanding (Basic)
    		 1.42M 6.84M 880.1K 186.19K
    Shares Outstanding (Diluted)
    		 1.42M 456.01K 880.3K 186.96K
    EPS (Basic)
    		 -10.19 -27.01 -16.53 -173.93
    EPS (Diluted)
    		 -10.19 -27.01 -16.53 -145.87
    EBITDA
    		 -14.86M -12.28M -15.15M -24.05M
    EBIT
    		 -14.45M -12.29M -15.31M -24.22M
    Depreciation & Amortization
    		 -409K 4K 167K 168K

    Add to Watchlist